🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Great work from ADCA and team during his MS fellowship (and beyond)

Great debate on the benefits of the de-escalation approach, featuring Dr. Tintore and Dr. Monreal. #movingsciencesummit2025 #Barcelona

Últimos cupos, no se lo pierdan. Presencial en Santiago de Chile y on-line a todo el mundo. 👇🏻 massoeventos.com/documents/2025…

In people with #MultipleSclerosis treated with ocrelizumab, progression independent of relapse activity occurred within suboptimal B-cell depletion, highlighting the need for monitoring and adjusted infusion intervals. Study from Universität Münster ▶️ journals.sagepub.com/doi/full/10.11…

Quedan muy pocos cupos presenciales pero aún puedes acompañarnos de forma Virtual desde todo el mundo 🌍🌎🌏! El programa ya está confirmado! No te lo pierdas! NeuroinmunologiaUC 🧠👁👁

Simposio UC de Esclerosis Múltiple y NeuroinmunologiaUC Expertos, casos reales y avances - Criterios McDonald 2024 - NMO, MOGAD - Anticd20 y NfL - Orhan Aktas - SOCHEDEM #EM #Neuroinmunología #McDonald2024 #NMO #MOGAD #SOCHEDEM

En Facultad Medicina UC y UC CHRISTUS hemos tenido el honor de recibir la visita del gran Joshua Klein Jefe de la División de Neurología Hospitalaria de Brigham and Women's Hospital y editor de “Adams and Victor's Principles of Neurology” Pasamos la ronda médica y nos ilustró con la conferencia

A 17-year-old boy with AQ4+ #NMOSD and treated with rituximab, had JCV+ progressive multifocal leukoencephalopathy #PML, which resulted into death. Case report from The Walton Centre Monash University ▶️journals.sagepub.com/doi/full/10.11… 1/🧵

En este 30 de Mayo, te conmemoramos a ti! #MS #EsclerosisMúltiple SOCHEDEM @neuroinmunuc instagram.com/reel/DKSJyS7pF…

Guess who we’ve poached for our Medical Advisory Board? 2 outstanding Drs & researchers. Congratulations to Dr EthelCiampiSCL & Dr Benjamin Greenberg. Both of these Drs have been pivotal in helping people around the globe understand #MOGAD & we are so grateful to have them in our

Extremely important. 24% of relapsing #MOGAD pts relapsed after discontinuation of treatment after 2 years. Relapsing MOGAD pts whose treatments were discontinued after a short period of time, also experienced higher risk of relapse, compared to monophasic patients. We really

📣 ¡Te invitamos a ser parte de la Escuela de Otoño en Neuroinmuno-Radiología! 🧠 Un curso intensivo diseñado para profundizar en el diagnóstico por imágenes en enfermedades desmielinizantes como EM, MOGAD y NMOSD. 📅 Miércoles 18 de junio | 17:00 a 20:00 (hora Chile)

Muchas gracias a los +140 participantes del hoy! Un honor estar junto a estos panelistas y compartir con colegas de todo #LATAM durante la sesión Q&A SOCHEDEM LACTRIMS NeuroinmunologiaUC

It is about pattern recognition... 🧠 Radiological patterns in autoimmune encephalitis... doi.org/10.1007/s00234…

Save the Date🗓 Join us on Monday July 7th! We'll be discussing the use of #sNFL on #DMT decision-making and how early #PIRA impacts disability accumulation in #MS🧠✌️ amazing speakers from #Argentina 🇦🇷 at our International Women in MS #iWiMS Conference NeuroinmunologiaUC SOCHEDEM Victoria Fernandez

Nos vemos el próximo miércoles 16/07 para discutir el uso de terapias de alta efectividad en pacientes pediátricos con #EsclerosisMultiple Cemcat SOCHEDEM International Women in MS #iWiMS #POMS #HET

Felicitamos a la Dra. Ethel Ciampi EthelCiampiSCL y Dra. Bernardita Soler por sus destacadas ponencias junto a la Dra. Mar Tintoré Mar Tintore (CEMCAT, Barcelona) sobre esclerosis múltiple pediátrica. Gran nivel científico y enriquecedora discusión. ¡Orgullo para la neuroinmunología !

🌍 What will the proposed 2024 McDonald Criteria mean for MS diagnosis globally? 📊 60% of countries face at least one obstacle to adopting the 2017 Criteria. Thailand & Chile offer key insights on access, equity & readiness. 📖 Read more: bit.ly/4kPn1lE #MS #MSResearch